Librede Receives a Phase I SBIR grant

 Librede receives a Phase I SBIR grant to develop cannabinoid production technology

Librede has been awarded a Phase I SBIR grant from the National Center for Complementary & Integrative Health. The project, Expression of Phytocannabinoids in Yeast: a High Yield Platform for Low Abundance Natural Products, will be lead by Dr. Farina, Chief Scientific Officer at Librede and co-inventor of Librede’s cannabinoid and drug discovery platform.